Rapport Therapeutics, Inc. RAPP
26.32 USD +0.88 (+3.44%)
Nov 4, 2026, 9:38 AM EST
26.06 Day range 26.27
22.06 52-week range 52.93
- YTD
- -13.26%
- 1 year
- -1.25%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 68.29 +159.5% upside
Now 26.32
- Target (low)
- 50.00
- Target (mean)
- 68.29
- Target (high)
- 91.00
Ratings (0m) 16 16 buy · 0 hold · 0 sell
- Strong buy1
- Buy15
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 16
- 1 month ago 13
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.22 | -1.36 – -1.08 | -0.71 | -72.1% | 0 | 0.0% | 12 |
| Next quarter | -1.20 | -1.54 – -0.81 | -0.72 | -66.2% | 66.67K | 0.0% | 12 |
| Current year | -4.04 | -4.51 – -3.50 | -2.86 | -41.2% | 20.06M | 0.0% | 12 |
| Next year | -5.09 | -6.80 – -3.81 | -4.04 | -26.0% | 0 | -100.0% | 12 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | Jones Trading | Maintained | Buy | Buy |
| Oct 21, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 21, 2026 | Guggenheim | Maintained | Buy | Buy |
| Oct 20, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 20, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 15, 2026 | UBS | Initiated | — | Buy |
| Oct 15, 2026 | Wolfe Research | Initiated | — | Outperform |
| Oct 6, 2026 | Guggenheim | Initiated | — | Buy |
| Sep 16, 2026 | BTIG | Maintained | Buy | Buy |
| Aug 19, 2026 | BTIG | Reiterated | Buy | Buy |
| Aug 12, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 5, 2026 | BTIG | Reiterated | Buy | Buy |
| Jul 16, 2026 | BTIG | Reiterated | Buy | Buy |
| Jun 24, 2026 | Leerink Partners | Initiated | — | Outperform |
| May 21, 2026 | BTIG | Maintained | Buy | Buy |
| May 8, 2026 | BTIG | Reiterated | Buy | Buy |
| Apr 22, 2026 | BTIG | Reiterated | Buy | Buy |
| Mar 11, 2026 | BTIG | Maintained | Buy | Buy |
| Mar 11, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 2, 2026 | Wells Fargo | Initiated | — | Overweight |
| Dec 9, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 8, 2025 | BTIG | Reiterated | Buy | Buy |
| Nov 19, 2025 | BTIG | Initiated | — | Buy |
| Nov 7, 2025 | Citizens | Maintained | Market Outperform | Market Outperform |
| Sep 16, 2025 | Truist Securities | Initiated | — | Buy |
| Sep 8, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 6, 2025 | HC Wainwright & Co. | Initiated | — | Buy |
| Jul 8, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Apr 8, 2025 | JMP Securities | Initiated | — | Market Outperform |
| Oct 18, 2024 | Jones Trading | Initiated | — | Buy |